The Human Paraoxonase Gene Cluster As a Target in the Treatment of Atherosclerosis-Reference-Cited by-同舟云学术

The Human Paraoxonase Gene Cluster As a Target in the Treatment of Atherosclerosis

Published:2012-03-15 Issue:6 Volume:16 Page:597-632
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

She Zhi-Gang¹,Chen Hou-Zao¹,Yan Yunfei¹,Li Hongliang¹,Liu De-Pei¹

Affiliation:

1. National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2010.3774

Reference365 articles.

1. Hepatic Effects of Rosiglitazone in Rats with the Metabolic Syndrome

2. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization

3. A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity

4. Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASGR1 is a promising target for lipid reduction in pigs with PON2 as its inhibitor;iScience;2024-07

2. Oxidative stress in polycystic ovary syndrome: a case- control study;Journal of the Pakistan Medical Association;2024-02-11

3. Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes;Biomolecules;2024-02-09

4. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency;Journal of Autoimmunity;2023-11

5. ПОШИРЕНІСТЬ ПОЛІМОРФІЗМУ ГЕНА PON1-108C/T У ХВОРИХ З РІЗНИМИ ТИПАМИ ЕНЦЕФАЛОПАТІЙ;Medical and Clinical Chemistry;2023-07-11